{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:27:52Z","timestamp":1790605672801,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4230,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Budd-Chiari syndrome (BCS) is a rare disorder that is characterized by hepatic venous outflow obstruction. The aim of this study was to assess determinants of survival and to evaluate the effect of portosystemic shunting. In this international multicenter study, 237 patients with BCS, diagnosed between 1984 and 2001, were investigated. Univariate, multivariate, and time-dependent Cox regression analyses were performed. Overall survival at 1, 5, and 10 years was 82% (95% CI, 77%-87%), 69% (95% CI, 62%-76%), and 62% (95% CI, 54%-70%), respectively. Encephalopathy, ascites, prothrombin time, and bilirubin were independent determinants of survival. A prognostic classification combining these factors could identify three classes of patients (classes I-III). The 5-year survival rate was 89% (95% CI, 79%-99%) for class I, 74% (95% CI, 65%-83%) for class II, and 42% (95% CI, 28%-56%) for class III. Anticoagulants were administered to 72%; only for patients in class I was this associated with a trend toward improved survival (relative risk [RR], 0.14; 95% CI, 0.02-1.21). Portosystemic shunting was performed in 49% of the patients (n = 117); only for patients in class II, time-dependent analyses suggested an improved survival (RR, 0.63; 95% CI, 0.26-1.49). In conclusion, at the time of diagnosis, patients with BCS can be classified into good (I), intermediate (II), and poor (III) prognostic classes, according to simple baseline clinical and laboratory parameters. Our results suggest an improved survival after surgical portosystemic shunting for patients with an intermediate prognosis (class II). (Hepatology 2004;39:500-508.)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.20064","type":"journal-article","created":{"date-parts":[[2004,2,3]],"date-time":"2004-02-03T12:05:53Z","timestamp":1075809953000},"page":"500-508","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":291,"title":["Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome"],"prefix":"10.1097","volume":"39","author":[{"given":"Sarwa Darwish","family":"Murad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique-Charles","family":"Valla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet C.","family":"de Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Zeitoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.M.","family":"Hopmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Haagsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20241201","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(02)00434-8","article-title":"Budd-Chiari syndrome: a review of an expert panel.","volume":"38","author":"Janssen","year":"2003","journal-title":"J Hepatol"},{"key":"R2-32-20241201","first-page":"276","article-title":"Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries.","volume":"115","author":"Panis","year":"1994","journal-title":"Surgery"},{"key":"R3-32-20241201","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0168-8278(01)00131-3","article-title":"The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome.","volume":"35","author":"Tang","year":"2001","journal-title":"J Hepatol"},{"key":"R4-32-20241201","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2002-23202","article-title":"Hepatic vein thrombosis (Budd-Chiari syndrome).","volume":"22","author":"Valla","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R5-32-20241201","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.qjmed.a030135","article-title":"Clinical spectrum, investigations and treatment of Budd-Chiari syndrome.","volume":"89","author":"Mahmoud","year":"1996","journal-title":"Qjm"},{"key":"R6-32-20241201","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199401000-00003","article-title":"Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature.","volume":"73","author":"Dilawari","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"R7-32-20241201","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/hep.510250405","article-title":"Hepatic venous outflow block caused by short-length hepatic vein stenoses.","volume":"25","author":"Valla","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R8-32-20241201","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"R9-32-20241201","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00000658-200009000-00006","article-title":"A 27-year experience with surgical treatment of Budd-Chiari syndrome.","volume":"232","author":"Orloff","year":"2000","journal-title":"Ann Surg"},{"key":"R10-32-20241201","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00000658-199111000-00008","article-title":"Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome.","volume":"214","author":"Bismuth","year":"1991","journal-title":"Ann Surg"},{"key":"R12-32-20241201","first-page":"603","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.","volume":"94","author":"Ganger","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R13-32-20241201","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1148\/radiology.197.3.7480760","article-title":"Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt.","volume":"197","author":"Blum","year":"1995","journal-title":"Radiology"},{"key":"R14-32-20241201","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000658-200104000-00007","article-title":"Budd-Chiari syndrome: current management options.","volume":"233","author":"Slakey","year":"2001","journal-title":"Ann Surg"},{"key":"R15-32-20241201","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gut.44.4.568","article-title":"Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.","volume":"44","author":"Fisher","year":"1999","journal-title":"Gut"},{"key":"R16-32-20241201","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.510300125","article-title":"Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting.","volume":"30","author":"Zeitoun","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R17-32-20241201","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0741-5214(89)90348-0","article-title":"Recognition and management of Budd-Chiari syndrome: report of one hundred cases.","volume":"10","author":"Wang","year":"1989","journal-title":"J Vasc Surg"},{"key":"R18-32-20241201","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.510280505","article-title":"Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion.","volume":"28","author":"Okuda","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R19-32-20241201","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0140-6736(93)91712-U","article-title":"Management of hepatic venous outflow obstruction.","volume":"342","author":"Kohli","year":"1993","journal-title":"Lancet"},{"key":"R20-32-20241201","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.","volume":"31","author":"Denninger","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R21-32-20241201","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/hep.1840210518","article-title":"Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients.","volume":"21","author":"Ringe","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R22-32-20241201","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1091-255X(97)80060-1","article-title":"Selective management of hepatic venous outflow obstruction.","volume":"1","author":"Tsiotos","year":"1997","journal-title":"J Gastrointest Surg"},{"key":"R23-32-20241201","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","article-title":"Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome.","volume":"103","author":"Valla","year":"1985","journal-title":"Ann Intern Med"},{"key":"R24-32-20241201","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0016-5085(94)90765-X","article-title":"The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases.","volume":"106","author":"Hadengue","year":"1994","journal-title":"Gastroenterology"},{"key":"R25-32-20241201","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","article-title":"Clinicopathological forms and prognostic index in Budd-Chiari syndrome.","volume":"39","author":"Langlet","year":"2003","journal-title":"J Hepatol"},{"key":"R26-32-20241201","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/jhep.2002.30274","article-title":"TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.","volume":"35","author":"Perello","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R27-32-20241201","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0676.1998.tb00132.x","article-title":"The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art.","volume":"18","author":"Rossle","year":"1998","journal-title":"Liver"},{"key":"R28-32-20241201","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510270224","article-title":"Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules.","volume":"27","author":"Tanaka","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R29-32-20241201","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/lt.500030410","article-title":"Reassessing the role of medical therapy in the management of hepatic vein thrombosis.","volume":"3","author":"Min","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"R30-32-20241201","first-page":"453","article-title":"Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome.","volume":"174","author":"Shaked","year":"1992","journal-title":"Surg Gynecol Obstet"},{"key":"R31-32-20241201","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01676885","article-title":"Liver transplantation for Budd-Chiari syndrome: a retrospective study.","volume":"24","author":"Sakai","year":"1994","journal-title":"Surg Today"},{"key":"R32-32-20241201","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000658-199001000-00007","article-title":"Liver transplantation for the Budd-Chiari syndrome.","volume":"211","author":"Halff","year":"1990","journal-title":"Ann Surg"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20064","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200402000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T07:11:24Z","timestamp":1733037084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200402000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20064","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}